OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE 12.5 mg/1 (OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE TABLET, FILM COATED) 12.5 mg/1

Olmesartan Medoxomil and Hydrochlorothiazide 12.5 mg/1 is a combination medication used to manage high blood pressure. This oral tablet combines two active ingredients to support cardiovascular health.

Strength

12.5 mg/1

Pack Size

1000 TABLET, FILM COATED in 1 BOTTLE (33342-173-44)

Manufacturer / TM Owner

Macleods Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Olmesartan Medoxomil and Hydrochlorothiazide 12.5 mg/1 is commonly used for the treatment of hypertension, or high blood pressure. Olmesartan works by relaxing blood vessels, while hydrochlorothiazide helps the kidneys remove excess salt and water from the body. This dual-action approach is often recommended for individuals who need additional support in managing their blood pressure levels.

Side Effects

Common effects of Olmesartan Medoxomil and Hydrochlorothiazide 12.5 mg/1 may include dizziness, fatigue, and mild stomach discomfort. Some users might experience a dry cough or changes in electrolyte levels. These effects vary and are not experienced by everyone.

Precautions & Warnings

It is important to use Olmesartan Medoxomil and Hydrochlorothiazide 12.5 mg/1 as directed by a healthcare professional. Individuals with kidney disease, liver disease, or those who are pregnant should discuss potential risks with their doctor. Regular monitoring of blood pressure and electrolyte levels is recommended.

Avoid Interactions

Olmesartan Medoxomil and Hydrochlorothiazide 12.5 mg/1 may interact with other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), lithium, and certain diabetes medications. Alcohol consumption should be limited, as it can exacerbate the effects of this medication. Always inform your healthcare provider about all medications you are taking.

Frequently Asked Questions

Olmesartan Medoxomil and Hydrochlorothiazide 12.5 mg/1 is primarily used to manage high blood pressure by combining two active ingredients that work together to support cardiovascular health.

This medication is taken orally, typically once daily, as directed by a healthcare professional. It should be taken with or without food, but consistency in timing is important.

Common side effects may include dizziness, fatigue, and mild stomach discomfort. Some users might also experience a dry cough or changes in electrolyte levels.

It is advisable to limit alcohol consumption while taking this medication, as alcohol can exacerbate certain side effects and interfere with the medication's effectiveness.

Individuals with severe kidney or liver disease, those who are pregnant, or anyone with a known allergy to the active ingredients should avoid taking this medication unless directed otherwise by a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.